Waning Immunity Most Consistent With Recent Mumps Outbreaks
TUESDAY, Jan. 10, 2023 (HealthDay News) -- A waning immunity model is most consistent with recently observed resurgent outbreaks of mumps in countries with high vaccine coverage, according to a study published online Jan. 9 in the Proceedings of the National Academy of Sciences.
Noting that multiple countries with high vaccine coverage have experienced resurgent outbreaks of mumps, Deven V. Gokhale, from the Odum School of Ecology at the University of Georgia in Athens, and colleagues proposed two putative mechanisms of vaccine failure as driving observed trends: gradual waning of immunity and the introduction of novel viral genotypes capable of evading vaccinal immunity. A statistical likelihood-based hypothesis testing was conducted using a mechanistic transmission model on age-structured epidemiological, demographic, and vaccine uptake time series data focusing on the United States.
The researchers found that the data were most consistent with the waning immunity model; by age 18 years, an estimated 32.8 percent of individuals had lost vaccine-derived immunity. The waning model reproduces features of the epidemiological data, including the shift in mumps incidence toward older individuals, recent recurrence of mumps outbreaks, and the high proportion of mumps cases among previously vaccinated individuals.
"We found that, due to the combination of waning immunity and primary vaccine failure, robust herd immunity cannot be achieved with the present vaccine and immunization schedule," the authors write. "Indeed, our results support, in principle, the administration of regular booster doses to achieve and maintain herd immunity."
Related Posts
Los hospitales de EE. UU. atienden a números récord de pacientes jóvenes con COVID
MARTES, 4 de enero de 2022 (HealthDay News) -- Las hospitalizaciones por la...
Report Shows World Ill-Prepared for Next Pandemic
MONDAY, Dec. 13, 2021 (HealthDay News) -- The world is not ready to prevent or...
Un experto responde tus preguntas sobre el cáncer de próstata
MARTES, 5 de septiembre de 2023 (Noticias HealthDay) -- Es fundamental que los...
Company Reaches $479 Million Settlement Over Defects in CPAP Machines
FRIDAY, Sept. 8, 2023 (HealthDay News) -- Philips Respironics has agreed to a...